Revenue ₹1,743 Cr (+22% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Gland Pharma LimitedGland Pharma delivered a strong Q4 FY26 with consolidated revenue of ₹1,742.8 crore (+22% YoY) and adjusted EBITDA ma...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.